The global Anatomic Pathology Market is estimated to be valued at US$ 30.16 billion in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The anatomic pathology market deals with the study of disease in human and animal tissue. Anatomic pathologists examine cells, tissues, and organs to diagnose and classify diseases. Anatomic pathology testing helps in early disease detection and customized treatment planning. It provides microscopic examination of biopsied or surgically removed tissues.
Market key trends:
One of the key trends in the anatomic pathology market is the increasing adoption of digital pathology. Digital pathology involves converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. It allows remote diagnosis, consults, and collaborations. Digital pathology offers benefits like rapid screening, integrated storage, and analysis of whole slide images. It enables AI applications for computer-assisted diagnosis and quantitative image analysis. The technology is gaining ground owing to advantages like enhanced efficiency, reduced turnaround time, and improved diagnostic accuracy.
Segment Analysis
The Global Anatomic Pathology Market is segmented into instruments, consumables and services. The consumables segment dominated the market in 2023 and is expected to remain the highest revenue generating segment during the forecast period. The increasing volume of diagnostic tests performed is driving the demand for consumables such as slides, cover slips, reagents, and staining kits. Also, the need for repeat purchase of consumables compared to instruments is contributing to the large share of this segment.
Key Takeaways
The global anatomic pathology market size was valued at US$ 30.16 billion in 2023 and is expected to witness high growth, exhibiting a CAGR of 8.7% over the forecast period from 2023 to 2030, due to the increasing prevalence of chronic and infectious diseases.
Regional analysis-
North America dominated the anatomic pathology market in 2023 and is expected to continue its dominance during the forecast period. This is attributed to the increasing healthcare expenditure, rising research activities in the field of cancer, and availability of technologically advanced instruments and consumables in the region.
Key players analysis-
Key players operating in the anatomic pathology market are Thermo Fisher Scientific, F. Hoffman-La Roche AG, Agilent Technologies, Danaher Corporation, Quest Diagnostics, Inc., Biocartis NV, and Sakura FineTechnical Co., Ltd. Some of the key strategies adopted by these players to increase their market share include new product launches, mergers & acquisitions, collaborations, and geographic expansions.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it